News
UCLA School of Dentistry and Dongwoon Anatech Launch Collaboration
Photo L to R: Amir Naiberg, AVC, CEO and President, UCLA Technology Development Group, Dr. Wong, Professor, UCLA School of Dentistry and Dong-Cheol Kim, CEO, Dongwoon Anatech
UCLA School of Dentistry and Dongwoon Anatech Launch Collaboration to Advance Saliva-Based Cancer Detection Technology
Sponsored Research Agreement will provide up to $787,500 annually to support Dr. David T.W. Wong's Electric Field-Induced Release and Measurement (EFIRM) platform.
UCLA TDG Innovation Magazine July 2025
UCLA TDG Innovation Magazine July 2025
It's our success story edition. Delve into >
*Bahram Jalali's Journey from Research to Commercialization
*UCLA startups that have reached media and funding milestones
*UCLA TDG updates including a new department name, Innovation Fund recipients and Ready-to-Sign Agreements
*Event wrap ups on the first LABEST Week 2025, UCLA Ventures Annual Dinner, Bruin Founders Cohorts and the quarterly Founders Mixers
and more...
Trethera Secures Exclusive License with UCLA

Trethera Secures New License, Strengthening TRE-515 Intellectual Property Portfolio and Extending Market Exclusivity to 2045
Nervonik Raises $13 Million in Series A Financing
Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief
LOS ANGELES, March 4, 2025 /PRNewswire/ -- Nervonik, Inc. (Nervonik), a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system, has successfully closed a $13 million Series A funding round. The round was led by U.S. Venture Partners (USVP), with participation from Foothill Ventures, Correlation Ventures, and other investors.
Bruin Founders now accepting startup and mentor applications

Bruin Founders, UCLA Ventures’ executive mentorship program, is now accepting startup and mentor applications - Deadline March 31st
UCLA TDG Expands LABEST in 2025
FOR IMMEDIATE RELEASE
UCLA TDG Expands LABEST for a Dynamic Week of Discovery and Advancement in Bioscience and MedTech
UCLA MedTech Conference and LABEST Bioscience Unite for a Powerhouse Event in May 2025
UCLA TDG Innovation Magazine Winter 2024

Welcome to the Winter 2024 Edition of UCLA TDG's Innovation Magazine.
This is our year-end wrap up with annual performance metrics and global rankings.
In this edition you will find stories on:
-Cytovale $100M Funding
-UCLA Innovation Fund supporting early stage research
-Lyell Immunopharma acquires ImmPACT Bio
-Pictor Labs $30M Funding